4th Quarter - Termination
STANTON PARK GROUP for WATSON PHARMACEUTICALS
Firm
Client
Income
$50,000
Expenses
—
Terminated
Dec 31, 2011
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Telecommunications TEC
junk fax regulations
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES DERDERIAN | LA, LD, Policy Advisor, Rep. Bliley |
| VALERIE HENRY | LA, Sen. John Warner; LA, Sen. Mike Crapo |
| ERIN STRAWN | SA, EA, LA, LD, Rep. C Weldon |
Copyright/Patent/Trademark CPT
Patent and settlements issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES DERDERIAN | CoS, House Commerce; LA, LD, Rep. Bliley |
| VALERIE HENRY | Policy Advisor, Rep. Walden |
| ERIN STRAWN | SA, EA, LA, LD Rep. C. Weldon |
Medicare/Medicaid MMM
Medicare and Medicaid reimbursement for pharmaceuticals. Reimbursement for prostate cancer drugs. Prevention of preterm birth.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES DERDERIAN | CoS, House Commerce; LA, LD, Rep. Bliley |
| VALERIE HENRY | Policy Advisor, Rep. Walden |
| ERIN STRAWN | SA, EA, LA, LD Rep. C. Weldon |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.